lymphocytic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

lym·pho·cyte

 (lĭm′fə-sīt′)
n.
Any of a class of white blood cells of the vertebrate immune system, including the B cells, T cells, and natural killer cells, that in mammals derive from a common progenitor in the bone marrow and are found chiefly in lymph, lymphoid tissues, and blood.

lym′pho·cyt′ic (-sĭt′ĭk) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.lymphocytic - of or relating to lymphocytes; "lymphocytic leukemia"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
The team created a compound using feverfew, a common flowering garden plant, to kill chronic lymphocytic leukaemia (CLL) cells.
MEI Pharma announced that updated data presented in an oral presentation at ICML 2019 from a Phase 1b study of investigational ME-401, a selective oral inhibitor of PI3K delta, demonstrate an 83% overall response rate in patients with relapsed or refractory follicular lymphoma and r/r chronic lymphocytic leukemia or small lymphocytic lymphoma.
M2 PHARMA-June 19, 2019-Calquence Significantly Prolonged the Time Patients Lived without Disease Progression in Relapsed or Refractory Chronic Lymphocytic Leukemia
AstraZeneca Plc (LON:AZN), a multinational pharmaceutical and biopharmaceutical company, reported on Monday detailed results from the interim analysis of the phase III ASCEND trial at the European Haematology Association (EHA) Annual Congress in Amsterdam, showing Calquence (acalabrutinib) significantly prolonged the time patients live without disease progression in relapsed or refractory chronic lymphocytic leukaemia (CLL).
AstraZeneca today announced detailed results from the interim analysis of the Phase III ASCEND trial at the European Hematology Association (EHA) Annual Congress in Amsterdam, showing Calquence (acalabrutinib) significantly prolonged the time patients live without disease progression in relapsed or refractory chronic lymphocytic leukaemia (CLL).
(Alliance News) - AstraZeneca PLC on Saturday said its drug Calquence significantly prolonged the time patients lived without disease progression in chronic lymphocytic leukaemia.
Chronic lymphocytic leukemia (CLL) is an adult hematologic cancer characterized by a significant expansion of small, mature-looking B-cells, in peripheral blood and lymphoid tissues.
When doctors diagnosed the eldest of her three children, James Anthony Laurenciana, with acute lymphocytic leukemia, Angelita Rio was not surprised.
Jessner's lymphocytic skin infiltration is a benign disease in which cutaneous T-lymphocyte infiltration with unknown etiology occurs (1).
T-cell large granular lymphocytic leukemia (T-LGLL) is a heterogeneous disorder affecting equally men and women, and characterized by expansion of the monoclonal population of large granular lymphocytes in peripheral blood (1).

Full browser ?